StockData
Elevance Health, Inc. logo

Elevance Health, Inc.

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)

Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –

Elevance Health Total Net Medical Claim Cash Payments by Quarter

Total Net Medical Claim Cash Payments ($M)

QuarterlyAnnual

Elevance Health Total Net Medical Claim Cash Payments: $36,816M in Q3 2026, down 1.4% from a year earlier.

Latest, Q3 2026
36,816
Period ended Sep 30, 2026
Change on a year earlier
-1.4%
37,325 in Q3 2025
History
43 quarters
Since Q1 2016
Sources
3
Documents cited below

Where the Q3 2026 figure comes from

“us-gaap:PaymentsForLossesAndLossAdjustmentExpense (2026-09-30): 106,045,000,000.00”

Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow / footnote)

Source: ELV 10-Q (XBRL us-gaap:PaymentsForLossesAndLossAdjustmentExpense) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal Net Medical Claim Cash Payments ($M)Year on yearSource
Q3 2026Sep 30, 202636,816-1.4%ELV 10-Q (XBRL us-gaap:PaymentsForLossesAndLossAdjustmentExpense) ↗
Q2 2026Jun 30, 202635,969+0.9%ELV 10-Q (XBRL us-gaap:PaymentsForLossesAndLossAdjustmentExpense) ↗
Q1 2026Mar 31, 202633,2600.0%ELV 10-Q (XBRL us-gaap:PaymentsForLossesAndLossAdjustmentExpense) ↗
Q4 2025Dec 31, 202537,162+15.1%ELV 10-K (XBRL us-gaap:PaymentsForLossesAndLossAdjustmentExpense) ↗
Q3 2025Sep 30, 202537,325+17.0%ELV 10-Q (XBRL us-gaap:PaymentsForLossesAndLossAdjustmentExpense) ↗
Q2 2025Jun 30, 202535,664+16.2%ELV 10-Q (XBRL us-gaap:PaymentsForLossesAndLossAdjustmentExpense) ↗
Q1 2025Mar 31, 202533,255+13.9%ELV 10-Q (XBRL us-gaap:PaymentsForLossesAndLossAdjustmentExpense) ↗
Q4 2024Dec 31, 202432,286+5.6%ELV 10-K (XBRL us-gaap:PaymentsForLossesAndLossAdjustmentExpense) ↗
Q3 2024Sep 30, 202431,906+8.1%ELV 10-Q (XBRL us-gaap:PaymentsForLossesAndLossAdjustmentExpense) ↗
Q2 2024Jun 30, 202430,695+2.0%ELV 10-Q (XBRL us-gaap:PaymentsForLossesAndLossAdjustmentExpense) ↗
Q1 2024Mar 31, 202429,186-1.2%ELV 10-Q (XBRL us-gaap:PaymentsForLossesAndLossAdjustmentExpense) ↗
Q4 2023Dec 31, 202330,566+5.7%ELV 10-K (XBRL us-gaap:PaymentsForLossesAndLossAdjustmentExpense) ↗
Q3 2023Sep 30, 202329,519+4.0%ELV 10-Q (XBRL us-gaap:PaymentsForLossesAndLossAdjustmentExpense) ↗
Q2 2023Jun 30, 202330,085+10.0%ELV 10-Q (XBRL us-gaap:PaymentsForLossesAndLossAdjustmentExpense) ↗
Q1 2023Mar 31, 202329,541+13.9%ELV 10-Q (XBRL us-gaap:PaymentsForLossesAndLossAdjustmentExpense) ↗
Q4 2022Dec 31, 202228,925+9.3%ELV 10-K (XBRL us-gaap:PaymentsForLossesAndLossAdjustmentExpense) ↗

Breakdown

What makes up total Net Medical Claim Cash Payments

Cite this data

StockData. (2026). Elevance Health Total Net Medical Claim Cash Payments ($M), quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/mcp-paid-total-net

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.